Free Trial
Earnings Season Is Here. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Best Biotechnology Stocks

Biotech stocks open the door to investing in innovation that’s shaping the future of healthcare. From pioneering drug developers to specialized firms in genetic engineering and diagnostics, this sector offers exposure to breakthroughs with the potential for transformative impact—and strong returns. These stocks are known for their potential for high growth but also come with significant volatility due to the complex nature of biotechnological development and regulatory environments.

The list below highlights some of the most widely followed biotech stocks in today’s market. It features a range of companies—from established leaders with approved therapies to up-and-coming firms advancing promising clinical pipelines. View each stock's current price, PE ratio, volume, and recent indicators of potential movement.

MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
0 Results
CompanyCurrent PriceP/E RatioMarket CapVolumeAverage VolumeIndicator(s)
AbbVie Inc. stock logo
ABBV
AbbVie
$285.66
+0.2%
80.69$504.67 billion4.63 million5.20 million
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$673.97
-0.4%
35.55$249.14 billion2.04 million2.45 million
Danaher Corporation stock logo
DHR
Danaher
$230.36
+0.3%
37.70$162.16 billion3.94 million4.91 million
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
$523.93
-2.1%
30.50$132.98 billion832,5741.23 million
GSK PLC Sponsored ADR stock logo
GSK
GSK
$50.75
-0.9%
15.87$102.65 billion3.18 million5.82 million
Moderna, Inc. stock logo
MRNA
Moderna
$200.10
-1.2%
N/A$79.89 billion21.51 million19.46 million
Lumentum Holdings Inc. stock logo
LITE
Lumentum
$756.17
+0.5%
N/A$68.50 billion3.91 million4.90 million
Takeda Pharmaceutical Co. stock logo
TAK
Takeda Pharmaceutical
$20.26
-0.5%
59.57$64.85 billion2.10 million2.81 million
Cencora, Inc. stock logo
COR
Cencora
$330.77
-2.3%
24.57$63.16 billion1.17 million1.25 million
Bloom Energy Corporation stock logo
BE
Bloom Energy
$192.52
-11.6%
118.11$56.93 billion35.86 million14.27 million
argenex SE stock logo
ARGX
argenex
$873.71
-0.2%
30.49$54.94 billion295,822509,396
Veeva Systems Inc. stock logo
VEEV
Veeva Systems
$323.31
+0.2%
53.18$52.30 billion1.37 million1.48 million
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$279.47
+0.4%
34.67$45.98 billion981,2091.32 million
Illumina, Inc. stock logo
ILMN
Illumina
$269.42
+0.0%
50.26$40.68 billion1.26 million2.69 million
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
$63.86
+0.2%
44.04$36.72 billion4.02 million3.02 million
Cognizant Technology Solutions Corporation stock logo
CTSH
Cognizant Technology Solutions
$70.54
-4.3%
15.17$31.77 billion6.35 million6.72 million
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$224.03
-1.4%
41.64$29.98 billion1.06 million1.31 million
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
$587.50
+0.5%
21.02$25.20 billion621,320926,008
International Flavors & Fragrances Inc. stock logo
IFF
International Flavors & Fragrances
$94.11
+0.3%
86.34$24.02 billion1.48 million1.89 million
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
$88.11
-1.7%
N/A$22.28 billion838,3771.11 million
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$669.20
+2.3%
37.10$18.68 billion309,423332,400
Revvity Inc. stock logo
RVTY
Revvity
$158.82
+0.9%
75.63$17.72 billion1.11 million1.85 million
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$345.08
+1.6%
N/A$16.49 billion822,2791.09 million
Icon Plc stock logo
ICLR
Icon
$185.27
-0.1%
43.49$14.19 billion1.02 million902,298
Fabrinet stock logo
FN
Fabrinet
$315.09
-0.8%
24.14$11.29 billion846,217922,195
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
$207.74
-0.9%
N/A$10.78 billion830,3441.70 million
Suzano S.A. Sponsored ADR stock logo
SUZ
Suzano
$8.63
+1.2%
6.85$10.71 billion3.92 million2.63 million
Bio-Rad Laboratories, Inc. stock logo
BIO.B
Bio-Rad Laboratories
$364.15
39.24$9.74 billion4124
10x Genomics stock logo
TXG
10x Genomics
$71.55
+2.6%
N/A$9.32 billion2.23 million4.20 million
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
$311.50
-2.7%
39.04$9.22 billion270,063275,726
Spyre Therapeutics, Inc. stock logo
SYRE
Spyre Therapeutics
$90.33
-2.2%
N/A$9.21 billion502,9781.50 million
Vaxcyte, Inc. stock logo
PCVX
Vaxcyte
$60.43
-3.9%
N/A$8.99 billion2.06 million3.85 million
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
$139.92
+3.3%
N/A$8.77 billion1.86 million3.21 million
ImmunityBio, Inc. stock logo
IBRX
ImmunityBio
$8.22
-1.1%
N/A$8.71 billion5.93 million16.12 million
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
$54.17
+1.9%
19.77$8.29 billion1.98 million1.53 million
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
$88.01
-2.5%
N/A$7.70 billion432,4521.28 million
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
$14.09
-0.4%
N/A$6.38 billion7.75 million16.63 million
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
$31.21
-0.3%
N/A$5.42 billion1.77 million2.22 million
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
$80.15
-1.2%
N/A$5.31 billion513,993915,699
JPMorgan U.S. Tech Leaders ETF stock logo
JTEK
JPMorgan U.S. Tech Leaders ETF
$98.56
+0.9%
47.07$4.51 billion368,441288,495
Financial legend: “This is bad, really bad...” (Ad)

Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.tc pixel

See Martin Weiss's full warning before this risk spreads further
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
$76.78
-2.2%
N/A$4.21 billion379,230983,230
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
$25.51
+4.5%
N/A$4.07 billion1.92 million2.11 million
Tutor Perini Corporation stock logo
TPC
Tutor Perini
$76.92
+0.1%
33.16$4.04 billion313,854385,270
Tango Therapeutics, Inc. stock logo
TNGX
Tango Therapeutics
$23.34
-16.4%
N/A$3.94 billion15.85 million3.85 million
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
$19.27
+2.0%
N/A$3.73 billion979,5652.00 million
Celcuity, Inc. stock logo
CELC
Celcuity
$65.25
-0.5%
N/A$3.19 billion1.31 million1.90 million
Hercules Capital, Inc. stock logo
HTGC
Hercules Capital
$16.40
-0.6%
8.16$3.07 billion891,8551.11 million
Standex International Corporation stock logo
SXI
Standex International
$240.27
-1.1%
27.71$2.95 billion320,371140,846
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
$18.41
-1.3%
N/A$2.94 billion1.01 million1.90 million
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
$15.62
-1.0%
N/A$2.92 billion2.13 million3.13 million
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
$22.37
-2.0%
N/A$2.53 billion1.18 million2.09 million
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
$24.05
-2.1%
N/A$2.48 billion1.60 million1.68 million
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
$23.63
-1.2%
N/A$2.25 billion999,7131.82 million
Redwire Corporation stock logo
RDW
Redwire
$8.40
+3.2%
N/A$2.09 billion10.04 million12.72 million
Immunome, Inc. stock logo
IMNM
Immunome
$17.99
-1.5%
N/A$2.04 billion1.38 million1.46 million
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
$27.99
-3.6%
N/A$2.02 billion1.98 million1.78 million
Zymeworks Inc. stock logo
ZYME
Zymeworks
$28.22
-0.8%
N/A$2.00 billion1.12 million1.36 million
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
$3.70
+3.4%
N/A$1.98 billion19.04 million30.68 million
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
$7.65
-1.7%
N/A$1.95 billion2.75 million5.48 million
Diversified Healthcare Trust stock logo
DHC
Diversified Healthcare Trust
$7.86
-0.1%
N/A$1.90 billion1.42 million1.86 million
Septerna, Inc. stock logo
SEPN
Septerna
$40.41
-1.1%
N/A$1.89 billion200,316410,976
ADRX
ADARx Pharmaceuticals
$17.63
-0.3%
N/A$1.88 billion177,561647,565
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
$10.57
+1.3%
N/A$1.79 billion1.69 million1.92 million
Urogen Pharma stock logo
URGN
Urogen Pharma
$34.49
-1.9%
N/A$1.69 billion738,0961.02 million
Kailera Therapeutics, Inc. stock logo
KLRA
Kailera Therapeutics
$12.85
-3.2%
N/A$1.67 billion1.56 million1.37 million
Hemab Therapeutics Holdings, Inc. stock logo
COAG
Hemab Therapeutics
$34.40
-1.2%
N/A$1.61 billion271,178410,495
Novavax, Inc. stock logo
NVAX
Novavax
$9.70
-2.9%
N/A$1.60 billion4.42 million8.95 million
Azenta, Inc. stock logo
AZTA
Azenta
$36.50
+1.4%
N/A$1.60 billion478,6781.24 million
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
$30.98
-3.5%
N/A$1.60 billion177,888536,410
Generate Biomedicines Inc stock logo
GENB
Generate Biomedicines
$12.41
-3.0%
N/A$1.59 billion295,605970,112
TRAX
First Tracks Biotherapeutics
$44.05
+2.1%
N/A$1.57 billion849,7921.20 million
Nanobiotix S.A. - Sponsored ADR stock logo
NBTX
Nanobiotix
$29.36
+0.6%
N/A$1.49 billion69,409152,212
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
$48.73
+1.3%
9.07$1.46 billion468,091582,829
Ascentage Pharma Group International - Unsponsored ADR stock logo
AAPG
Ascentage Pharma Group International
$15.40
+3.2%
N/A$1.45 billion9,3837,410
ODDITY Tech Ltd. stock logo
ODD
ODDITY Tech
$22.65
-3.0%
94.38$1.30 billion461,198714,255
Damora Therapeutics, Inc. Common Stock stock logo
DMRA
Damora Therapeutics, Inc. Common Stock
$21.09
-2.9%
N/A$1.30 billion359,783526,259
Rapport Therapeutics, Inc. stock logo
RAPP
Rapport Therapeutics
$25.93
-2.3%
N/A$1.24 billion1.18 million896,457
Tyra Biosciences, Inc. stock logo
TYRA
Tyra Biosciences
$20.45
-2.0%
N/A$1.22 billion520,381720,123
Silence Therapeutics PLC Sponsored ADR stock logo
SLN
Silence Therapeutics
$19.67
+0.1%
N/A$1.18 billion2.13 million5.55 million
abrdn Healthcare Investors stock logo
HQH
abrdn Healthcare Investors
$20.27
-0.7%
N/A$1.16 billion135,372199,531
Replimune Group, Inc. stock logo
REPL
Replimune Group
$11.46
-4.4%
N/A$1.07 billion1.90 million2.00 million
Oaktree Specialty Lending Corp. stock logo
OCSL
Oaktree Specialty Lending
$11.44
-0.1%
23.83$1.01 billion300,433495,764
Monte Rosa Therapeutics, Inc. stock logo
GLUE
Monte Rosa Therapeutics
$10.84
-2.4%
N/A$924.79 million817,8261.53 million
Rigel Pharmaceuticals, Inc. stock logo
RIGL
Rigel Pharmaceuticals
$48.13
-1.5%
2.95$890.50 million119,260218,155
Phreesia, Inc. stock logo
PHR
Phreesia
$12.67
-0.4%
74.51$788.30 million696,514665,307
Transcat, Inc. stock logo
TRNS
Transcat
$81.92
+0.1%
221.41$769.09 million163,817134,721
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
$2.33
-1.7%
N/A$697.51 million1.71 million3.35 million
Adlai Nortye Ltd. Sponsored ADR stock logo
ANL
Adlai Nortye
$10.58
N/A$681.33 million79,538332,599
OmniAb, Inc. stock logo
OABI
OmniAb
$4.66
-2.5%
N/A$674.69 million1.28 million1.37 million
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
$9.98
+2.7%
N/A$672.73 million1.15 million3.73 million
Why tech stocks are dead (Ad)

AI skeptics see dot-com era warning signs, and they have a point. But the real opportunity may not be in the big tech names pouring billions into data centers. Walmart's $24 million satellite network, AMR's Sabre system, and Capital One's 36,114 pricing tests all prove the same thing: compute has always been business's biggest moat, and it's about to get cheaper than ever. Porter Stansberry says one overlooked, government-protected sector is positioned to absorb this near-free compute boom and could become the next Magnificent 7.tc pixel

Watch Porter Stansberry's broadcast to see which sector could lead next
Prime Medicine, Inc. stock logo
PRME
Prime Medicine
$3.67
-1.6%
N/A$665.65 million4.56 million5.17 million
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
$6.30
-2.5%
N/A$653.34 million721,844940,909
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
$3.18
-5.1%
N/A$627.19 million2.66 million3.17 million
SLR Investment Corp. stock logo
SLRC
SLR Investment
$11.17
-0.8%
8.27$609.38 million424,930378,246
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
$10.80
-8.9%
N/A$596.64 million996,1291.07 million
Climb Bio, Inc. stock logo
CLYM
Climb Bio
$10.19
-3.3%
N/A$585.27 million495,6791.03 million
Puma Biotechnology, Inc. stock logo
PBYI
Puma Biotechnology
$11.02
-2.1%
21.19$568.85 million559,155348,719
Shattuck Labs, Inc. stock logo
STTK
Shattuck Labs
$5.49
-2.0%
N/A$550.99 million700,4881.38 million
Anbio Biotechnology stock logo
NNNN
Anbio Biotechnology
$3.81
+2.7%
N/A$548.22 million25,84257,426
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
$17.71
-1.4%
N/A$539.13 million60,790128,755

Frequently Asked Questions

Biotech stocks represent shares of companies in the biotechnology sector, which focuses on using biological processes, organisms, or systems to develop products that improve health, fight diseases, and benefit the environment. This sector includes companies that work on drug development, genetic research, biologically derived materials, and more. Due to the innovative and often breakthrough nature of their work, biotech stocks are known for their volatility but also for their potential to offer substantial returns.

Prominent players in the biotech sector include large, well-established companies such as Amgen, Gilead Sciences, and Biogen, which have multiple products on the market and solid research pipelines. Younger companies like Moderna and Regeneron are also notable, especially for their roles in developing treatments and vaccines at an accelerated pace in response to global health crises. These companies represent a mix of stable investments and high-growth potentials within the biotech industry.

While biotech exists in other areas, the majority of the biotech stocks are in the medical and agricultural sectors. Investors might choose individual stocks of companies they believe have potential based on their pipelines or existing products. However, due to the high risk associated with the biotech sector, many opt to diversify their exposure through biotech ETFs or mutual funds, which include a range of companies from startups to established leaders. This strategy can mitigate some of the risks while allowing investors to benefit from the sector's overall growth.

Before investing in biotech stocks, consider the unique risks of this sector, including high development costs, regulatory hurdles, and the binary nature of clinical trial results, which can dramatically affect a company's stock price. Investors should be prepared for volatility and have a tolerance for risk. It is also crucial to research and understand the specific focus areas of biotech companies, as these can vary widely from medical devices and pharmaceuticals to agricultural and environmental biotechnologies. Consulting with a financial advisor who understands the biotech sector can provide valuable insights and guidance tailored to your financial goals.